RNAFinance•prnewswire•
Avidity Biosciences Announces Proposed Public Offering of Common Stock
Sentiment:Negative (15)
Summary
(NASDAQ:RNA) SAN DIEGO, Sept. 10, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that it intends to offer and sell, subject to market...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 10, 2025 by prnewswire